Your session is about to expire
← Back to Search
Calcium Channel Blocker
Amlodipine for Hypertension
Phase 4
Waitlist Available
Research Sponsored by Prisma Health-Upstate
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through hospital stay, on average 2-5 days
Awards & highlights
Study Summary
This trial is testing if amlodipine is just as effective as nifedipine ER in managing hypertension in postpartum women.
Eligible Conditions
- Pregnancy-Induced Hypertension (PIH)
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through hospital stay, on average 2-5 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through hospital stay, on average 2-5 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Length of stay
Secondary outcome measures
Breastfeeding duration
Antihypertensive Agents
Number of patients discontinuing medication due to side effects
+3 moreSide effects data
From 2019 Phase 4 trial • 44 Patients • NCT0203443513%
IV infiltration or malfunction
6%
Pain
100%
80%
60%
40%
20%
0%
Study treatment Arm
Aim 2- Amlodipine
Aim 1- Low Sodium
Aim 2- Eplerenone
Aim 1- High Sodium
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: AmlodipineExperimental Treatment1 Intervention
Group II: Nifedipine ERActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Amlodipine
FDA approved
Find a Location
Who is running the clinical trial?
Prisma Health-UpstateLead Sponsor
83 Previous Clinical Trials
42,896 Total Patients Enrolled
1 Trials studying Hypertension
202 Patients Enrolled for Hypertension
Share this study with friends
Copy Link
Messenger